KemPharm News

8-K: Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates

5minutes ago

8-K: Current report

Sep 21 04:13

8-K: Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

Aug 14 04:24

8-K: Current report

Aug 10 05:08

8-K: Current report

Aug 9 04:18

8-K: Current report

Aug 6 02:07

8-K: Current report

Jul 13 04:42

8-K: Current report

Jul 9 21:25

S-3: Registration statement for specified transactions by certain issuers

Jun 5 05:18

8-K: Current report

Jun 4 05:13

8-K: Current report

May 14 04:51

8-K: Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates

May 8 19:58

DEFA14A: Others

Apr 29 19:53

KemPharm | 8-K: Current report

Apr 10 19:47

KemPharm | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Apr 9 02:08

KemPharm | DEFA14A: Others

Apr 4 04:59

KemPharm | DEF 14A: Definitive information statements

Apr 4 04:20

KemPharm | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 3 02:11

KemPharm | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 3 02:11

KemPharm | 8-K: Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

Mar 29 04:45